Dyne Therapeutics, Inc.
DYN
$12.58
$0.362.95%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -110.86M | -115.36M | -89.54M | -97.13M | -65.10M |
| Total Depreciation and Amortization | 503.00K | 502.00K | 450.00K | 438.00K | 399.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.01M | 12.57M | 9.84M | 7.88M | 5.59M |
| Change in Net Operating Assets | 5.64M | -3.60M | -5.09M | 14.18M | 4.24M |
| Cash from Operations | -94.70M | -105.89M | -84.34M | -74.63M | -54.87M |
| Capital Expenditure | -60.00K | -981.00K | -1.08M | -253.00K | -857.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.83M | 2.44M | -14.94M | -19.15M | 12.03M |
| Cash from Investing | 6.77M | 1.46M | -16.01M | -19.40M | 11.17M |
| Total Debt Issued | 98.80M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.97M | 141.24M | 3.64M | 18.01M | 379.86M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 100.77M | 141.24M | 3.64M | 18.01M | 379.86M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.85M | 36.81M | -96.71M | -76.02M | 336.17M |